Ferring acquires licensing rights for Elobixibat, ... PICOPREP® (sodium picosulfate 10mg, magnesium oxide 3.5mg, citric acid 12g), a dual action laxative medication, ...

Ferring Pharmaceuticals has licensed the rights to Albireo of Sweden’s elobixibat, ... for inflammatory bowel disease and Picoprep (sodium picosulfate) for bowel cleansing. Tags. Related posts. VarmX ...

Ferring Pharmaceuticals has acquired the rights to develop and commercialize elobixibat from Albireo, according to a news release. Elobixibat is a compound for chronic idiopathic constipation and ...

The agreement gives Ferring rights to market the product globally with limited exceptions. "Elobixibat perfectly complements our gastroenterology portfolio, which includes PENTASA for IBD and PICOPREP ...

The agreement gives Ferring rights to market the product globally with the exception of Japan and a small number of Asian markets. In consideration of the rights, Ferring will pay Albireo a ...